Borislava (Boby) Mihaylova
Borislava (Boby) Mihaylova
Verified email at dph.ox.ac.uk
Title
Cited by
Cited by
Year
Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
19015*2014
Heart disease and stroke statistics—2018 update: a report from the American Heart Association
EJ Benjamin, SS Virani, CW Callaway, AM Chamberlain, AR Chang, ...
Circulation, 2018
44932018
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
Cholesterol Treatment Trialists' Collaboration
The Lancet 380 (9841), 581-590, 2012
1991*2012
Efficacy and safety of LDL‐lowering therapy among men and women: meta‐analysis of individual data from 174,000 participants in 27 randomised trials
Cholesterol Treatment Trialists' Collaboration
The Lancet 385 (9976), 1397-1405, 2015, 2015
674*2015
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ...
European heart journal 41 (1), 111-188, 2020
589*2020
Review of statistical methods for analysing healthcare resources and costs
B Mihaylova, A Briggs, A O'Hagan, SG Thompson
Health economics 20 (8), 897-916, 2011
4702011
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals
Heart Protection Study Collaborative Group
The Lancet 365 (9473), 1779-1785, 2005
1472005
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
J Armitage, C Baigent, E Barnes, DJ Betteridge, L Blackwell, M Blazing, ...
The Lancet 393 (10170), 407-415, 2019
1392019
The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84)
ML Alva, A Gray, B Mihaylova, J Leal, RR Holman
Diabetic Medicine 32 (4), 459-466, 2015
1272015
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20 536 people
Heart Protection Study Collaborative
Bmj 333 (7579), 1145, 2006
1002006
Cholesterol Treatment Trialists’(CTT) Collaboration. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants …
J Fulcher, R O’connell, M Voysey, J Emberson, L Blackwell, B Mihaylova, ...
Lancet 385 (9976), 1397-1405, 2015
902015
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
W Herrington, J Emberson, B Mihaylova, L Blackwell, C Reith, R Haynes, ...
Lancet Diabetes and Endocrinology 4 (10), 2016
882016
Clinical and cost effectiveness of growth hormone in children
J Bryant, C Cave, B Mihaylova, D Chase, L McIntyre, K Gerard, R Milne, ...
Health Technology Assessment 6 (18), 1-175, 2001
732001
The effect of diabetes complications on health‐related quality of life: the importance of longitudinal data to address patient heterogeneity
M Alva, A Gray, B Mihaylova, P Clarke
Health economics 23 (4), 487-500, 2014
702014
ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ...
Eur Heart J 41, 111-188, 2019
592019
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study
A Briggs, B Mihaylova, M Sculpher, A Hall, J Wolstenholme, M Simoons, ...
Heart 93 (9), 1081-1086, 2007
59*2007
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
CT Trialists
The Lancet Diabetes & Endocrinology 4 (10), 829-839, 2016
58*2016
Statin cost-effectiveness in the United States for people at different vascular risk levels
Heart Protection Study Collaborative Group
Circulation: Cardiovascular Quality and Outcomes, 2009
572009
Body mass index and healthcare costs: a systematic literature review of individual participant data studies
S Kent, F Fusco, A Gray, SA Jebb, BJ Cairns, B Mihaylova
Obesity Reviews 18 (8), 869-879, 2017
532017
Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis
YB Vergel, S Palmer, C Asseburg, E Fenwick, M de Belder, K Abrams, ...
Heart 93 (10), 1238-1243, 2007
502007
The system can't perform the operation now. Try again later.
Articles 1–20